Network Pharmacology Strategy to Investigate the Pharmacological Mechanism of Siwu Decoction on Primary Dysmenorrhea and Molecular Docking Verification

Table 1

General data on the active compounds in the SWD.

Medicine	Active compound	Compound ID	OB (%)	DL
RPA	11α,12α-Epoxy-3beta-23-dihydroxy-30-norolean-20-en-28, 12beta-olide	MOL001910	64.77	0.38
RPA	Paeoniflorgenone	MOL001918	87.59	0.37
RPA	(3S,5R,8R,9R,10S,14S)-3,17-Dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9-hexahydro-1H-cyclopenta[a]phenanthrene-15,16-dione	MOL001919	43.56	0.53
RPA	Lactiflorin	MOL001921	49.12	0.80
RPA	Paeoniflorin	MOL001924	53.87	0.79
RPA	Paeoniflorin_qt	MOL001925	68.18	0.4
RPA	Albiflorin_qt	MOL001928	66.64	0.33
RPA	Benzoyl paeoniflorin	MOL001930	31.27	0.75
RPA	Mairin	MOL000211	55.38	0.78
RPA	Beta-sitosterol	MOL000358	36.91	0.75
RAS
RPA	Sitosterol	MOL000359	36.91	0.75
RC
RRP
RPA	Kaempferol	MOL000422	41.88	0.24
RPA	(+)-Catechin	MOL000492	54.83	0.24
RC	Mandenol	MOL001494	42.00	0.19
RC	Myricanone	MOL002135	40.60	0.51
RC	Perlolyrine	MOL002140	65.95	0.27
RC	Senkyunone	MOL002151	47.66	0.24
RC	Wallichilide	MOL002157	42.31	0.71
RC	FA	MOL000433	68.96	0.71
RAS	Stigmasterol	MOL000449	43.83	0.76
RRP